Product NDC: | 51672-1312 |
Proprietary Name: | Mupirocin |
Non Proprietary Name: | Mupirocin |
Active Ingredient(s): | 20 mg/g & nbsp; Mupirocin |
Administration Route(s): | TOPICAL |
Dosage Form(s): | OINTMENT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51672-1312 |
Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065170 |
Marketing Category: | ANDA |
Start Marketing Date: | 20050923 |
Package NDC: | 51672-1312-0 |
Package Description: | 1 TUBE in 1 CARTON (51672-1312-0) > 22 g in 1 TUBE |
NDC Code | 51672-1312-0 |
Proprietary Name | Mupirocin |
Package Description | 1 TUBE in 1 CARTON (51672-1312-0) > 22 g in 1 TUBE |
Product NDC | 51672-1312 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Mupirocin |
Dosage Form Name | OINTMENT |
Route Name | TOPICAL |
Start Marketing Date | 20050923 |
Marketing Category Name | ANDA |
Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
Substance Name | MUPIROCIN |
Strength Number | 20 |
Strength Unit | mg/g |
Pharmaceutical Classes | RNA Synthetase Inhibitor Antibacterial [EPC],RNA Synthetase Inhibitors [MoA] |